158 related articles for article (PubMed ID: 28204853)
61. Detectability of liver metastases in malignant melanoma: prospective comparison of magnetic resonance imaging and positron emission tomography.
Ghanem N; Altehoefer C; Högerle S; Nitzsche E; Lohrmann C; Schäfer O; Kotter E; Langer M
Eur J Radiol; 2005 May; 54(2):264-70. PubMed ID: 15837408
[TBL] [Abstract][Full Text] [Related]
62. Gadoxetic acid-enhanced 3.0 T MR imaging versus multidetector-row CT in the detection of colorectal metastases in fatty liver using intraoperative ultrasound and histopathology as a standard of reference.
Berger-Kulemann V; Schima W; Baroud S; Koelblinger C; Kaczirek K; Gruenberger T; Schindl M; Maresch J; Weber M; Ba-Ssalamah A
Eur J Surg Oncol; 2012 Aug; 38(8):670-6. PubMed ID: 22652037
[TBL] [Abstract][Full Text] [Related]
63. [Evaluation of Efficiencies on the Gadoxetic Acid-enhanced MRI for Preoperative Assessment of Liver Metastases from Colorectal Carcinoma].
Iwata K; Moriya T; Nakagawa S; Ogasawara K
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2018; 74(1):29-38. PubMed ID: 29353834
[TBL] [Abstract][Full Text] [Related]
64. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
[TBL] [Abstract][Full Text] [Related]
65. Diagnosis of colorectal hepatic metastases: Contrast-enhanced ultrasonography versus contrast-enhanced computed tomography versus superparamagnetic iron oxide-enhanced magnetic resonance imaging with diffusion-weighted imaging.
Muhi A; Ichikawa T; Motosugi U; Sou H; Nakajima H; Sano K; Kitamura T; Faima Z; Fukushima K; Araki T; Iino H; Mori Y; Fujii H
J Magn Reson Imaging; 2010 Nov; 32(5):1132-40. PubMed ID: 21031519
[TBL] [Abstract][Full Text] [Related]
66. Accuracy of liver-specific magnetic resonance imaging as a predictor of chemotherapy-associated hepatic cellular injury prior to liver resection.
O'Rourke TR; Welsh FK; Tekkis PP; Lyle N; Mustajab A; John TG; Peppercorn D; Rees M
Eur J Surg Oncol; 2009 Oct; 35(10):1085-91. PubMed ID: 19246171
[TBL] [Abstract][Full Text] [Related]
67. The application of abbreviated MRI protocols in malignant liver lesions surveillance.
Winder M; Grabowska S; Hitnarowicz A; Barczyk-Gutkowska A; Gruszczyńska K; Steinhof-Radwańska K
Eur J Radiol; 2023 Jul; 164():110840. PubMed ID: 37141846
[TBL] [Abstract][Full Text] [Related]
68. Magnetic Resonanance Imaging of the Liver (Including Biliary Contrast Agents)-Part 2: Protocols for Liver Magnetic Resonanance Imaging and Characterization of Common Focal Liver Lesions.
Agostini A; Kircher MF; Do RK; Borgheresi A; Monti S; Giovagnoni A; Mannelli L
Semin Roentgenol; 2016 Oct; 51(4):317-333. PubMed ID: 27743568
[No Abstract] [Full Text] [Related]
69. Dual contrast liver MRI: a pictorial illustration.
Welle CL; Venkatesh SK; Reeder SB; VanBuren WM; Wells ML; Sheedy SP; Fidler JL
Abdom Radiol (NY); 2021 Oct; 46(10):4588-4600. PubMed ID: 34076723
[TBL] [Abstract][Full Text] [Related]
70. c-Met-Targeting
Li D; Yang J; Xu Z; Li Y; Sun Y; Wang Y; Zou H; Wang K; Yang L; Wu L; Sun X
Int J Nanomedicine; 2023; 18():2181-2196. PubMed ID: 37131548
[TBL] [Abstract][Full Text] [Related]
71. Liver MRI in patients scheduled for local therapy of colorectal liver metastases.
Vernuccio F
Lancet Oncol; 2024 Jan; 25(1):9-10. PubMed ID: 38081199
[No Abstract] [Full Text] [Related]
72. Abbreviated MRI Protocols for the Abdomen.
Canellas R; Rosenkrantz AB; Taouli B; Sala E; Saini S; Pedrosa I; Wang ZJ; Sahani DV
Radiographics; 2019; 39(3):744-758. PubMed ID: 30901285
[TBL] [Abstract][Full Text] [Related]
73. Targeted MRI contrast agents for pediatric hepatobiliary disease.
Courtier JL; Perito ER; Rhee S; Tsai P; Heyman MB; MacKenzie JD
J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):454-62. PubMed ID: 22193178
[TBL] [Abstract][Full Text] [Related]
74. Enhancing Clinical Decision-Making: The Impact of Liver Contrast-enhanced MRI on Local Treatment Plans for Colorectal Liver Metastases.
Lin YM
Radiol Imaging Cancer; 2024 Jan; 6(1):e239023. PubMed ID: 38240670
[No Abstract] [Full Text] [Related]
75. Benign focal liver lesions: The role of magnetic resonance imaging.
Gatti M; Maino C; Tore D; Carisio A; Darvizeh F; Tricarico E; Inchingolo R; Ippolito D; Faletti R
World J Hepatol; 2022 May; 14(5):923-943. PubMed ID: 35721295
[TBL] [Abstract][Full Text] [Related]
76. Gadofosveset-enhanced magnetic resonance imaging as a problem-solving tool for diagnosing colorectal liver metastases: a case report.
Cheung H; Karanicolas P; Coburn N; Law C; Milot L
Quant Imaging Med Surg; 2018 Apr; 8(3):360-363. PubMed ID: 29774188
[TBL] [Abstract][Full Text] [Related]
77. Particulate contrast agents for improved ultrasound detection of liver metastases.
Violante MR; Parker K; Lerner R
Invest Radiol; 1990 Sep; 25 Suppl 1():S165-6. PubMed ID: 2283241
[No Abstract] [Full Text] [Related]
78. Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases.
Granata V; Fusco R; Petrillo A
AJR Am J Roentgenol; 2021 Jul; 217(1):W1. PubMed ID: 34010035
[No Abstract] [Full Text] [Related]
79. Reply to "Additional Considerations on Use of Abbreviated Liver MRI in Patients With Colorectal Liver Metastases".
Riddell AM; Torkzad MR; Koh DM
AJR Am J Roentgenol; 2021 Jul; 217(1):W2-W3. PubMed ID: 34010037
[No Abstract] [Full Text] [Related]
80. The Management of Colorectal Cancer Liver Metastases: The Interventional Radiology Viewpoint.
Rice SL; Bale R; Breen DJ; de Baere T; Denys A; Guiu B; Goldberg N; Kim E; Lewandowski RJ; Helmberger T; Mejerjink M; Pereira PL; Solbiati L; Solomon SB; Sofocleous CT
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):537-539. PubMed ID: 30722965
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
